(Pahernik et al., 1998). Understanding the mechanisms that lead to cellular resistance may be more effective in developing new treatments forbile duct cancer(BDC).CD44is a cellular and multi-structural surface marker. It is involved incell differentiation,cell proliferation,angiogenesis, cell ...
Liver and Bile Duct Cancer Ghassan K.Abou-Alfa, ...Eileen M.O'Reilly, inAbeloff's Clinical Oncology (Fifth Edition), 2014 Bile Duct Carcinoma One of the most technically difficult surgical resections is in patients withbile ducttumors arising in the hepatic hilus, namedKlatskin tumors, orhila...
Gemcitabine, oxaliplatin and 5-fluorouracil (5-FU) are active in biliary tract cancer and have a potentially synergistic mode of action and non-overlapping toxicity. The objective of these trials was to determine response, survival and toxicity separately in patients with bile duct cancer (BDC) an...
Primary sclerosing cholangitis at an advanced stage a: on the magnetic resonance cholangiography image in MIP volume rendering mode, there are multiple tight stenoses of the common bile duct, right and left hepatic ducts and intrahepatic bile ducts, plus dilatations of the intrahepatic bile ducts;...